VisionCare Ophthalmic Technologies, Inc. announced that it has secured up to $15 Million in long-term, non-dilutive financing to accelerate the commercialization of its novel therapy. The capital was raised exclusively from Life Sciences Alternative Funding LLC.
Samsara Vision, Inc.
Equities
SMSA
US79600A1051
Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | |
---|---|---|
+13.39% | 129B | |
-9.21% | 11.02B | |
-16.57% | 7.27B | |
+41.54% | 5.64B | |
-31.48% | 4.02B | |
+8.95% | 3.45B | |
-19.67% | 2.47B | |
-16.74% | 1.91B | |
-23.55% | 1.71B |